ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:
Browse All Topics

Home

Are the Brains of Geniuses Different?

Cognitive deficits have been extensively studied, but what could be gained from studying the brain activity of highly intelligent individuals?

 

© VLADGRIN/Shutterstock.com

Topics

Browse All Topics
Browse All Content

Recent Content

Phantom Limb Pain: Current Therapies

Heidi Moawad, MD
News | September 19, 2016
By

Patients with phantom limb pain may benefit best from tailored therapy based on individual pain response coupled with attention to side effects.

Interesting Neuro: ECTRIMS News & Alzheimer Marker

Samantha J. Peterson
News | September 16, 2016 | ECTRIMS 2016, Alzheimer disease, Epilepsy and Seizure, Headache and Migraine, Multiple sclerosis, Parkinson disease, Stroke, TBI
By

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

ECTRIMS 2016: Managing MS Symptoms

Samantha J. Peterson
Conference Report | September 15, 2016 | ECTRIMS 2016, Multiple sclerosis
By

Research presented at this ECTRIMS session covered management of multiple sclerosis-related fatigue, cognitive issues, and gait impairment.

New Imaging Techniques: MS Neuroprotection & Repair

Samantha J. Peterson
Conference Report | September 15, 2016 | ECTRIMS 2016, Multiple sclerosis
By

This ECTRIMS session includes studies using 7T and 3T MRI images and translocator protein PET scans, as well as phenotypes in gray matter and more.

Early Relapsing-Remitting MS: Induction vs Escalation

Samantha J. Peterson
Conference Report | September 14, 2016 | ECTRIMS 2016, Multiple sclerosis
By

Hot Topics session at ECTRIMS 2016: treat early active RRMS with potent induction therapy or immunomodulation then escalation? Where do you stand?

ECTRIMS 2016: Young MS Investigators’ Research

Samantha J. Peterson
Conference Report | September 14, 2016 | ECTRIMS 2016, Multiple sclerosis
By

The session featured a study comparing MRI criteria for diagnosing MS, the role of spinal cord volume loss in predicting disease activity, and more.

Impact of IV Glyburide after Hemispheric Stroke

Veronica Hackethal, MD
News | September 08, 2016 | Stroke
By

The study is the first RCT to look at the impact of early treatment with IV glyburide on cerebral edema after large hemispheric stroke.

View More Videos
View More Slideshows

By clicking Accept, you agree to become a member of the UBM Medica Community.